SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2CU'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 ASN A 108 THR A 187 ALA A 194 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) None IXO A 501 (-3.5A) 2CU A 502 ( 3.9A)	0.90A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 ASN A 108 TRP A 155 THR A 187 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	0.87A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 194 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.91A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 108 ALA A 194 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.5A) 2CU A 502 ( 3.9A)	0.85A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 108 TRP A 155 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) 2CU A 502 ( 3.9A)	0.74A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 TRP A 155 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.98A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.06A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ALA A 194 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.93A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 THR A 187 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.04A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.28A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 TRP A 155 THR A 187 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.02A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	TYR A 104 SER A 107 ASN A 108 TRP A 155 TYR A 426	IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) 2CU A 502 ( 3.9A)	1.19A	4dajA-4mqtA: 32.7	4dajA-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 SER A 107 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.4A) IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.06A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 THR A 187 THR A 190 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) None None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.93A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 194 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.97A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.97A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.20A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.38A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 THR A 187 THR A 190 ALA A 194 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.93A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 THR A 187 THR A 190 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.81A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	1.09A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_B_0HKB2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 TYR A 104 TRP A 155 THR A 187 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	0.91A	4dajB-4mqtA: 32.3	4dajB-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 ASN A 108 THR A 187 THR A 190 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-4.3A) None None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.93A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 SER A 107 ASN A 108 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.01A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 SER A 107 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.4A) IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.10A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 THR A 187 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.50A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 THR A 187 THR A 190 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) None None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.03A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 ASN A 108 THR A 187 THR A 190 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.84A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 ASN A 108 TRP A 155 THR A 187 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	0.93A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 108 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.86A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_C_0HKC2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 TYR A 104 THR A 187 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.19A	4dajC-4mqtA: 25.8	4dajC-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 SER A 107 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.4A) IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.08A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 THR A 187 THR A 190 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) None None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.03A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	ASP A 103 TYR A 104 ASN A 108 THR A 187 THR A 190 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) None None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.95A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 ASN A 108 TRP A 155 THR A 187 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.98A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 108 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.96A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 ASN A 108 TRP A 155 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-4.3A) IXO A 501 (-3.6A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.91A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DAJ_D_0HKD2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.48A	4dajD-4mqtA: 33.1	4dajD-4mqtA: 44.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 TYR A 104 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.17A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 191 ALA A 194 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.5A) 2CU A 502 ( 3.9A)	0.99A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 191 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.99A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	1.13A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ILE A 72 ASP A 103 TYR A 104 THR A 187 ALA A 191 ALA A 194 TYR A 426	None IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None IXO A 501 (-3.5A) 2CU A 502 ( 3.9A)	0.98A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	ILE A 72 ASP A 103 TYR A 104 THR A 187 ALA A 191 ASN A 404 TYR A 426 CYH A 429	None IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.89A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U14_A_0HKA2000_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ILE A 72 ASP A 103 TYR A 104 TRP A 155 THR A 187 TYR A 426	None IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A)	1.03A	4u14A-4mqtA: 33.1	4u14A-4mqtA: 45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	9 / 12	ASP A 103 TYR A 104 SER A 107 THR A 187 THR A 190 ALA A 191 ALA A 194 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.95A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	9 / 12	ASP A 103 TYR A 104 SER A 107 THR A 187 THR A 190 ALA A 191 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.87A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 TRP A 155 THR A 187 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.02A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.18A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.39A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_A_0HKA2001_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.38A	4u15A-4mqtA: 33.3	4u15A-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	ASP A 103 TYR A 104 SER A 107 THR A 190 ALA A 191 ALA A 194 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None IXO A 501 (-3.5A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.88A	4u15B-4mqtA: 33.6	4u15B-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	9 / 12	ASP A 103 TYR A 104 SER A 107 THR A 190 ALA A 191 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.98A	4u15B-4mqtA: 33.6	4u15B-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U15_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.21A	4u15B-4mqtA: 33.6	4u15B-4mqtA: 49.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 191 ALA A 194 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.79A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 ALA A 191 TRP A 400 ASN A 404 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-4.6A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	0.90A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 TRP A 155 ALA A 194 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) IXO A 501 (-3.5A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.75A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 SER A 107 TRP A 155 TRP A 400 TYR A 426	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) IXO A 501 (-4.6A) 2CU A 502 ( 3.9A)	0.93A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.36A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	TYR A 104 SER A 107 ALA A 191 TRP A 400 TYR A 403 ASN A 404 TYR A 426	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-4.6A) IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A)	1.07A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CXV_A_0HKA501_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARI NIC ACETYLCHOLINE RECEPTOR M1)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	TYR A 104 SER A 107 ALA A 191 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.90A	5cxvA-4mqtA: 32.6	5cxvA-4mqtA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 THR A 187 THR A 190 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.87A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	ASP A 103 TYR A 104 SER A 107 TRP A 155 THR A 187 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.01A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 THR A 187 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.30A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	ASP A 103 TYR A 104 TRP A 155 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.4A) IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.45A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	TYR A 104 SER A 107 THR A 187 THR A 190 ALA A 194 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.81A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	8 / 12	TYR A 104 SER A 107 THR A 187 THR A 190 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.94A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_A_0HKA1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	TYR A 104 SER A 107 TRP A 155 THR A 187 ALA A 194 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) None IXO A 501 (-3.5A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.93A	5dsgA-4mqtA: 32.8	5dsgA-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	TYR A 104 SER A 107 THR A 190 ALA A 194 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.5A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.70A	5dsgB-4mqtA: 33.7	5dsgB-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	7 / 12	TYR A 104 SER A 107 THR A 190 TYR A 403 ASN A 404 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) None IXO A 501 (-3.8A) IXO A 501 (-3.0A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.87A	5dsgB-4mqtA: 33.7	5dsgB-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	6 / 12	TYR A 104 SER A 107 TRP A 155 ALA A 194 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.4A) IXO A 501 (-3.6A) IXO A 501 (-3.5A) 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	0.74A	5dsgB-4mqtA: 33.7	5dsgB-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	TYR A 104 THR A 187 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.7A) None None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.28A	5dsgB-4mqtA: 33.7	5dsgB-4mqtA: 60.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	4mqt	MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (Homo sapiens)	5 / 12	TYR A 104 TRP A 155 ALA A 191 TYR A 426 CYH A 429	IXO A 501 (-3.7A) IXO A 501 (-3.6A) None 2CU A 502 ( 3.9A) IXO A 501 (-3.5A)	1.44A	5dsgB-4mqtA: 33.7	5dsgB-4mqtA: 60.18

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;ASN A 108;THR A 187;ALA A 194;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);None;IXO A 501 (-3.5A);2CU A 502 ( 3.9A)","0.90A","4dajA-4mqtA:32.7",null],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;ASN A 108;TRP A 155;THR A 187;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","0.87A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ALA A 194;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.91A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ASN A 108;ALA A 194;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.5A);2CU A 502 ( 3.9A)","0.85A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ASN A 108;TRP A 155;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);2CU A 502 ( 3.9A)","0.74A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;TRP A 155;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.98A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.06A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ALA A 194;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.93A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;THR A 187;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.04A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.28A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;TRP A 155;THR A 187;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.02A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"TYR A 104;SER A 107;ASN A 108;TRP A 155;TYR A 426","IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);2CU A 502 ( 3.9A)","1.19A","4dajA-4mqtA:32.7","4dajA-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;SER A 107;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.4A);IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.06A","4dajB-4mqtA:32.3","4dajA-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;THR A 187;THR A 190;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);None;None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.93A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ALA A 194;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.97A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.97A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.20A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.38A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;THR A 187;THR A 190;ALA A 194;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.93A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;THR A 187;THR A 190;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.81A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","1.09A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_B_0HKB2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;TYR A 104;TRP A 155;THR A 187;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","0.91A","4dajB-4mqtA:32.3","4dajB-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;ASN A 108;THR A 187;THR A 190;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-4.3A);None;None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.93A","4dajC-4mqtA:25.8","4dajB-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;SER A 107;ASN A 108;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.01A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;SER A 107;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.4A);IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.10A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;THR A 187;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.50A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;THR A 187;THR A 190;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);None;None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.03A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;ASN A 108;THR A 187;THR A 190;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.84A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;ASN A 108;TRP A 155;THR A 187;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","0.93A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ASN A 108;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.86A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_C_0HKC2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;TYR A 104;THR A 187;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.19A","4dajC-4mqtA:25.8","4dajC-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;SER A 107;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.4A);IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.08A","4dajD-4mqtA:33.1","4dajC-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;THR A 187;THR A 190;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);None;None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.03A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"ASP A 103;TYR A 104;ASN A 108;THR A 187;THR A 190;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);None;None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.95A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;ASN A 108;TRP A 155;THR A 187;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.98A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;ASN A 108;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.96A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;ASN A 108;TRP A 155;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-4.3A);IXO A 501 (-3.6A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.91A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4DAJ_D_0HKD2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3, LYSOZYME","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.48A","4dajD-4mqtA:33.1","4dajD-4mqtA:44.24"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;TYR A 104;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.17A","4u14A-4mqtA:33.1","4dajD-4mqtA:44.24"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;ALA A 191;ALA A 194;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.5A);2CU A 502 ( 3.9A)","0.99A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;ALA A 191;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.99A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","1.13A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ILE A  72;ASP A 103;TYR A 104;THR A 187;ALA A 191;ALA A 194;TYR A 426","None;IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;IXO A 501 (-3.5A);2CU A 502 ( 3.9A)","0.98A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"ILE A  72;ASP A 103;TYR A 104;THR A 187;ALA A 191;ASN A 404;TYR A 426;CYH A 429","None;IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.89A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U14_A_0HKA2000_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ILE A  72;ASP A 103;TYR A 104;TRP A 155;THR A 187;TYR A 426","None;IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A)","1.03A","4u14A-4mqtA:33.1","4u14A-4mqtA:45.70"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",9,"ASP A 103;TYR A 104;SER A 107;THR A 187;THR A 190;ALA A 191;ALA A 194;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.95A","4u15A-4mqtA:33.3","4u14A-4mqtA:45.70"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",9,"ASP A 103;TYR A 104;SER A 107;THR A 187;THR A 190;ALA A 191;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.87A","4u15A-4mqtA:33.3","4u15A-4mqtA:49.31"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;TRP A 155;THR A 187;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.02A","4u15A-4mqtA:33.3","4u15A-4mqtA:49.31"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.18A","4u15A-4mqtA:33.3","4u15A-4mqtA:49.31"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.39A","4u15A-4mqtA:33.3","4u15A-4mqtA:49.31"],["4U15_A_0HKA2001_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.38A","4u15A-4mqtA:33.3","4u15A-4mqtA:49.31"],["4U15_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"ASP A 103;TYR A 104;SER A 107;THR A 190;ALA A 191;ALA A 194;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;IXO A 501 (-3.5A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.88A","4u15B-4mqtA:33.6","4u15A-4mqtA:49.31"],["4U15_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",9,"ASP A 103;TYR A 104;SER A 107;THR A 190;ALA A 191;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.98A","4u15B-4mqtA:33.6","4u15B-4mqtA:49.31"],["4U15_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.21A","4u15B-4mqtA:33.6","4u15B-4mqtA:49.31"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"ASP A 103;TYR A 104;SER A 107;ALA A 191;ALA A 194;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.79A","5cxvA-4mqtA:32.6","4u15B-4mqtA:49.31"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;ALA A 191;TRP A 400;ASN A 404;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-4.6A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","0.90A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;TRP A 155;ALA A 194;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);IXO A 501 (-3.5A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.75A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;SER A 107;TRP A 155;TRP A 400;TYR A 426","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);IXO A 501 (-4.6A);2CU A 502 ( 3.9A)","0.93A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.36A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"TYR A 104;SER A 107;ALA A 191;TRP A 400;TYR A 403;ASN A 404;TYR A 426","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-4.6A);IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A)","1.07A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5CXV_A_0HKA501_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M1","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"TYR A 104;SER A 107;ALA A 191;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.90A","5cxvA-4mqtA:32.6","5cxvA-4mqtA:41.67"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;THR A 187;THR A 190;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.87A","5dsgA-4mqtA:32.8","5cxvA-4mqtA:41.67"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"ASP A 103;TYR A 104;SER A 107;TRP A 155;THR A 187;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.01A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;THR A 187;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.30A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"ASP A 103;TYR A 104;TRP A 155;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.4A);IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.45A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"TYR A 104;SER A 107;THR A 187;THR A 190;ALA A 194;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.81A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",8,"TYR A 104;SER A 107;THR A 187;THR A 190;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.94A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_A_0HKA1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"TYR A 104;SER A 107;TRP A 155;THR A 187;ALA A 194;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);None;IXO A 501 (-3.5A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.93A","5dsgA-4mqtA:32.8","5dsgA-4mqtA:60.18"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"TYR A 104;SER A 107;THR A 190;ALA A 194;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.5A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.70A","5dsgB-4mqtA:33.7","5dsgA-4mqtA:60.18"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",7,"TYR A 104;SER A 107;THR A 190;TYR A 403;ASN A 404;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);None;IXO A 501 (-3.8A);IXO A 501 (-3.0A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.87A","5dsgB-4mqtA:33.7","5dsgB-4mqtA:60.18"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",6,"TYR A 104;SER A 107;TRP A 155;ALA A 194;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.4A);IXO A 501 (-3.6A);IXO A 501 (-3.5A);2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","0.74A","5dsgB-4mqtA:33.7","5dsgB-4mqtA:60.18"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"TYR A 104;THR A 187;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.7A);None;None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.28A","5dsgB-4mqtA:33.7","5dsgB-4mqtA:60.18"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","4mqt","MUSCARINIC ACETYLCHOLINE RECEPTOR M2","Homo sapiens",5,"TYR A 104;TRP A 155;ALA A 191;TYR A 426;CYH A 429","IXO A 501 (-3.7A);IXO A 501 (-3.6A);None;2CU A 502 ( 3.9A);IXO A 501 (-3.5A)","1.44A","5dsgB-4mqtA:33.7","5dsgB-4mqtA:60.18"]]